tradingkey.logo
怜玢
マヌケット
ニュヌス
分析
ツヌル
株匏スクリヌナヌ


English
繁䜓䞭文
à¹„àž—àž¢
Tiếng việt
简䜓䞭文
Español
Português
Deutsch
한국얎
日本語

tradingkey.logo
怜玢



Upstream Bio Inc

UPB
りォッチリストに远加
6.520USD
+0.220+3.49%
取匕時間 ET15分遅れの株䟡
354.82M時䟡総額
損倱額盎近12ヶ月PER

Upstream Bio Inc

6.520
+0.220+3.49%
抂芁
金融
ディスカッション
分析
䌁業名
プロフィヌル収益株䞻統蚈䌁業情報

抂芁

金融

ディスカッション

分析

䌁業名

プロフィヌル収益株䞻統蚈䌁業情報

株䞻

曎新時刻: Thu, May 14
曎新時刻: Thu, May 14
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Fidelity Management & Research Company LLC
13.36%
OrbiMed Advisors, LLC
10.46%
Access Industries, Inc.
10.10%
Decheng Capital LLC
5.78%
Norges Bank Investment Management (NBIM)
5.30%
他の
55.01%
株䞻統蚈
株䞻統蚈
比率
Fidelity Management & Research Company LLC
13.36%
OrbiMed Advisors, LLC
10.46%
Access Industries, Inc.
10.10%
Decheng Capital LLC
5.78%
Norges Bank Investment Management (NBIM)
5.30%
他の
55.01%
皮類
株䞻統蚈
比率
Investment Advisor
43.95%
Investment Advisor/Hedge Fund
17.68%
Corporation
14.62%
Venture Capital
11.88%
Private Equity
10.46%
Hedge Fund
8.62%
Sovereign Wealth Fund
5.30%
Research Firm
0.96%
Bank and Trust
0.19%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
235
56.28M
103.41%
+2.57M
2025Q4
184
50.20M
92.89%
+454.99K
2025Q3
146
50.98M
94.34%
+856.75K
2025Q2
141
56.33M
104.50%
+7.82M
2025Q1
136
58.61M
109.21%
+10.01M
2024Q4
100
57.72M
107.69%
+27.36M

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Fidelity Management & Research Company LLC
7.27M
13.36%
-564.91K
-7.21%
Dec 31, 2025
OrbiMed Advisors, LLC
5.69M
10.46%
--
--
Dec 31, 2025
Access Industries, Inc.
5.49M
10.1%
+5.49M
--
Oct 15, 2024
Decheng Capital LLC
3.14M
5.78%
-142.22K
-4.33%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
2.88M
5.3%
--
--
Dec 31, 2025
Enavate Sciences GP, LLC
2.46M
4.52%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
2.30M
4.23%
+257.40K
+12.58%
Dec 31, 2025
HBM Partners AG
2.20M
4.03%
-519.95K
-19.15%
Sep 30, 2025
Janus Henderson Investors
1.53M
2.81%
+1.53M
--
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Virtus LifeSci Biotech Clinical Trials ETF
1.51%
ALPS Medical Breakthroughs ETF
0.58%
State Street SPDR S&P Biotech ETF
0.27%
Fidelity Fundamental Small-Mid Cap ETF
0.24%
iShares Health Innovation Active ETF
0.18%
Direxion Daily S&P Biotech Bull 3X Shares
0.13%
Avantis US Small Cap Equity ETF
0.1%
Fidelity Enhanced Small Cap ETF
0.07%
iShares Russell 2000 Value ETF
0.06%
ProShares Hedge Replication ETF
0.04%
詳现を芋る
Virtus LifeSci Biotech Clinical Trials ETF
比率1.51%
ALPS Medical Breakthroughs ETF
比率0.58%
State Street SPDR S&P Biotech ETF
比率0.27%
Fidelity Fundamental Small-Mid Cap ETF
比率0.24%
iShares Health Innovation Active ETF
比率0.18%
Direxion Daily S&P Biotech Bull 3X Shares
比率0.13%
Avantis US Small Cap Equity ETF
比率0.1%
Fidelity Enhanced Small Cap ETF
比率0.07%
iShares Russell 2000 Value ETF
比率0.06%
ProShares Hedge Replication ETF
比率0.04%
KeyAI
î™